|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| (11) | Number of the document | 3083681 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14833579.7 |
| Date of filing the European patent application | 2014-12-22 | |
| (97) | Date of publication of the European application | 2016-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation | 2020-11-25 |
| (86) | Number | PCT/EP2014/079094 |
| Date | 2014-12-22 |
| (87) | Number | WO 2015/092077 |
| Date | 2015-06-25 |
| (30) | Number | Date | Country code |
| 13199251 | 2013-12-20 | EP |
| (72) |
GRIMM, Jan, CH
MICHALON, Aubin, CH
|
| (73) |
Neurimmune Holding AG,
Wagistrasse 18, 8952 Schlieren,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Transtiretino (TTR) amiloidozės terapija antikūnų pagrindu ir jai skirti iš žmogaus organizmo gauti antikūnai |
| ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR |
| Payment date | Validity (years) | Amount | |
| 2024-12-03 | 11 | 289.00 EUR |
| 2025-12-22 |